Rx Labeling Final Rule Largely In Line With Draft Version
This article was originally published in The Pink Sheet Daily
Executive Summary
New labeling format will apply initially to recently approved drugs and products receiving approval for new uses, agency says.
You may also be interested in...
US FDA References Off-Label Use In Otherwise Bland Labeling Draft Guidance
Product labels can be required to have warnings related to commonly prescribed unapproved uses with significant safety risks.
Pregnancy Labeling Changes May Spur Research, FDA Says
Final regulation eliminates use of letter-based categories to designate level of risk during pregnancy and lactation; in a change from the 2008 proposed rule, information relevant to drug effects on reproductive potential will now be housed in dedicated section.
FDA’s Label Conversion Project Would Revise Data As Well As Reformat
Solicitation asks for contractor to reformat labels to physician labeling rule format, including updates with new information from literature; generic companies like contractor, while brands say it will be resource-intensive for industry and FDA.